全文获取类型
收费全文 | 10087篇 |
免费 | 613篇 |
国内免费 | 43篇 |
专业分类
耳鼻咽喉 | 120篇 |
儿科学 | 358篇 |
妇产科学 | 193篇 |
基础医学 | 1376篇 |
口腔科学 | 331篇 |
临床医学 | 1032篇 |
内科学 | 2089篇 |
皮肤病学 | 206篇 |
神经病学 | 845篇 |
特种医学 | 678篇 |
外国民族医学 | 1篇 |
外科学 | 1225篇 |
综合类 | 155篇 |
一般理论 | 2篇 |
预防医学 | 856篇 |
眼科学 | 151篇 |
药学 | 648篇 |
中国医学 | 4篇 |
肿瘤学 | 473篇 |
出版年
2021年 | 92篇 |
2019年 | 112篇 |
2018年 | 152篇 |
2017年 | 106篇 |
2016年 | 132篇 |
2015年 | 155篇 |
2014年 | 166篇 |
2013年 | 347篇 |
2012年 | 415篇 |
2011年 | 419篇 |
2010年 | 284篇 |
2009年 | 261篇 |
2008年 | 381篇 |
2007年 | 399篇 |
2006年 | 410篇 |
2005年 | 390篇 |
2004年 | 316篇 |
2003年 | 305篇 |
2002年 | 289篇 |
2001年 | 311篇 |
2000年 | 304篇 |
1999年 | 228篇 |
1998年 | 152篇 |
1997年 | 158篇 |
1996年 | 165篇 |
1995年 | 115篇 |
1994年 | 135篇 |
1993年 | 135篇 |
1992年 | 187篇 |
1991年 | 192篇 |
1990年 | 207篇 |
1989年 | 216篇 |
1988年 | 180篇 |
1987年 | 192篇 |
1986年 | 179篇 |
1985年 | 207篇 |
1984年 | 164篇 |
1983年 | 132篇 |
1982年 | 85篇 |
1981年 | 103篇 |
1980年 | 110篇 |
1979年 | 128篇 |
1978年 | 99篇 |
1977年 | 91篇 |
1976年 | 88篇 |
1975年 | 92篇 |
1972年 | 78篇 |
1970年 | 76篇 |
1965年 | 72篇 |
1960年 | 78篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
1.
Arjenne H.M. Gussenhoven Amika S. Singh S. Theo Goverts Marten van Til Johannes R. Anema Sophia E. Kramer 《International journal of audiology》2015,54(8):507-517
Objective: A multidisciplinary vocational rehabilitation programme, the Vocational Enablement Protocol (VEP) was developed to address the specific needs of employees with hearing difficulties. In the current study we evaluated the process of implementing the VEP in audiologic care among employees with hearing impairment. Design: In conjunction with a randomized controlled trial, we collected and analysed data on seven process parameters: recruitment, reach, fidelity, dose delivered, dose received and implemented, satisfaction, and perceived benefit. Study sample: Sixty-six employees with hearing impairment participated in the VEP. The multidisciplinary team providing the VEP comprised six professionals. Results: The professionals performed the VEP according to the protocol. Of the recommendations delivered by the professionals, 31% were perceived as implemented by the employees. Compliance rate was highest for hearing-aid uptake (51%). Both employees and professionals were highly satisfied with the VEP. Participants rated good perceived benefit from it. Conclusions: Our results indicate that the VEP could be a useful treatment for employees with hearing difficulties from a process evaluation perspective. Implementation research in the audiological setting should be encouraged in order to further provide insight into parameters facilitating or hindering successful implementation of an intervention and to improve its quality and efficacy. 相似文献
2.
3.
4.
5.
K. KARNICKI† R. D. MCBANE II † R. S. MILLER† R. J. Leadley JR ¶ J. MORSER W. G. OWEN†‡ J. H. CHESEBRO§ 《Journal of thrombosis and haemostasis》2004,2(12):2162-2169
BACKGROUND/OBJECTIVE: The efficacy of a direct factor (F)Xa inhibitor, ZK-807834, was compared with indirect inhibition by enoxaparin for inhibition and deaggregation of acute platelet-rich thrombi in a well-characterized porcine carotid injury model. METHODS: A crush injury was performed on a randomly chosen carotid artery and the thrombus allowed to propagate for 30 min. Pigs then received intravenous drug for 35 min: ZK-807834-Dose 1 (40 microg kg(-1) bolus + 1.5 microg kg(-1) min(-1) infusion, n=6); ZK-807834-Dose 2 (20 microg kg(-1) bolus + 0.75 microg kg(-1) min(-1) infusion; n=6); enoxaparin (1 mg kg(-1) bolus; n=6); or saline (n=6). Five minutes after drug initiation, the contralateral artery was injured. Thrombus size was monitored by scintillation detection of autologous 111In-platelets. RESULTS: The prothrombin time ratio was 2.2 +/- 0.1; 1.4 +/- 0.3; 1.2 +/- 0.9 and 1.1 +/- 0.2, respectively. ZK-807834-Dose 1 significantly inhibited carotid platelet deposition (525 +/- 226 x 10(6) cm(-2); P = 0.008), whereas ZK-807834-Dose 2 (2325 +/- 768) and enoxaparin (1236 +/- 383) were not different from saline (2776 +/- 642). Thrombus deaggregation was greatest for animals receiving ZK-807834-Dose 1 (473 +/- 185). Neither ZK-807834-Dose 2 (1588 +/- 480) nor enoxaparin (1618 +/- 686) was different from saline control (2222 +/- 598). CONCLUSIONS: Direct FXa inhibition with ZK-807834, at a prothrombin time ratio of 2.2, effectively inhibits thrombosis and promptly deaggregates thrombi induced by arterial injury. In contrast, indirect FXa inhibition with enoxaparin was ineffective. 相似文献
6.
7.
8.
10.